Back
10x Genomics Vs. P3 Health Partners Industry Stock Comparison
Sell
33
TXG
10x Genomics
Last Price:
14.87
Seasonality Move:
22.6%
Sell
26
PIII
P3 Health Partners
Last Price:
0.48
Seasonality Move:
-47.79%
Sell
33
10x Genomics (TXG)
is a Sell
Is 10x Genomics a Buy, Sell or Hold?
- The current 10x Genomics [TXG] share price is $15.74. The Score for TXG is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- TXG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
P3 Health Partners (PIII)
is a Sell
Is P3 Health Partners a Buy, Sell or Hold?
- The current P3 Health Partners [PIII] share price is $0.37. The Score for PIII is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- PIII is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TXG Stock Price Chart
What is 10x Genomics's stock price today?
-
The 10x Genomics share price today is $15.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TXG is experiencing slight selling pressure.
PIII Stock Price Chart
What is P3 Health Partners's stock price today?
-
The P3 Health Partners share price today is $0.37
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PIII is experiencing slight buying pressure.
TXG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.53 | Sell |
| Relative Strength Index (14 RSI): | 30.84 | Sell |
| Chaikin Money Flow: | -794897 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18 - 22.94) | Sell |
| Bollinger Bands (100): | (18.46 - 22.54) | Sell |
PIII Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 43.47 | Sell |
| Chaikin Money Flow: | 248518 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.34 - 0.46) | Sell |
| Bollinger Bands (100): | (0.42 - 0.6) | Sell |
TXG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.58 | Sell |
| 20-day SMA: | 20.09 | Sell |
| 50-day SMA: | 21.18 | Sell |
| 200-day SMA: | 29.37 | Sell |
| 8-day EMA: | 17.28 | Sell |
| 20-day EMA: | 19.17 | Sell |
| 50-day EMA: | 20.51 | Sell |
| 200-day EMA: | 27.84 | Sell |
PIII Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.34 | Buy |
| 20-day SMA: | 0.37 | Sell |
| 50-day SMA: | 0.46 | Sell |
| 200-day SMA: | 0.72 | Sell |
| 8-day EMA: | 0.35 | Buy |
| 20-day EMA: | 0.38 | Sell |
| 50-day EMA: | 0.44 | Sell |
| 200-day EMA: | 0.78 | Sell |
10x Genomics Earnings Growth & TXG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.28 per share.
P3 Health Partners Earnings Growth & PIII Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.14 per share.
10x Genomics Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
P3 Health Partners Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||